Source: Business Wire

Press Release: KeenEye Technologies : Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies

PARIS--(BUSINESS WIRE)--#IrisPharma--Keen Eye and Iris Pharma team up to bring AI in the preclinical ophthalmic drug development to make assays faster, more reliable and more efficient.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Sylvain Berlemont's photo - Founder & CEO of KeenEye Technologies

Founder & CEO

Sylvain Berlemont

CEO Approval Rating

62/100

Read more